To enquire about specific property features for 48 Lilly Pilly Way, Kiama, contact the agent. What is the size of the property at 48 Lilly Pilly Way, Kiama? The external land size for 48 Lilly ...

Eli Lilly's growth is impressive, driven by Mounjaro and Zepbound, but its current valuation is only justifiable with sustained high growth. Despite strong results and superior products ...

A clinical trial showed that Lilly's weight loss medicine is superior to a key competitor's product. The drug giant has several other selling points, including a deep lineup and pipeline.

Farm garden mainstays for many years, glorious rhodos are regaining their popularity, and 'Cunningham's White' is Marina Shearer from Rhodo Direct's top choice. "She will grow nearly anywhere, is ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index ...

Pretty much everyone on the show—other than Michaela—wears Lilly Pulitzer, to the point where you might be wondering...literally why. And apparently creator Molly Smith Metzler was simply ...

Hedge funds loaded up on shares of Lam Research Corp. and Micron Technology Inc. in the first quarter, according to research from Goldman Sachs. And investors may want to take a cue from the hedge ...

Hedge funds shifted focus from the Magnificent Seven to other stocks in the first quarter. Goldman Sachs identified 20 stocks with increased hedge fund interest in that period. Stocks with rising ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. A caller asked what Cramer’s thoughts on Eli Lilly ...

A big uplift in short positions on stocks has driven hedge fund gross leverage — borrowing cash to boost returns — to a record high, according to data by Goldman Sachs. A dramatic upsurge in ...

A surge in long-term bond yields is once again threatening to upend a crowded hedge-fund bet that Treasuries will perform better than interest-rate swaps. The trade is at risk of falling apart as ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential sites for new drug ingredients plants. Eli Lilly is jockeying for a ...